Xuefu Zhuyu Decoction on Heart Failure Patients with Middle-Range Coronary Heart Disease with Ejection Fraction
نویسندگان
چکیده
To investigate the impact of Xuefu Zhuyu decoction on cardiac remodeling and quality life patients with heart failure middle-range coronary disease ejection fraction is main objective study. 116 in middle range were divided as observation or control group. Clinical efficacy both groups was observed changes traditional Chinese medicine symptom scores, function classification, exercise tolerance, ultrasound indexes compared before after treatment between groups. Relative to treatment, left ventricular two enhanced dramatically (p<0.05) enddiastolic diameter increased significantly (p<0.05). Serum N-terminal pro-B-type natriuretic peptide end-systolic declined physical limitation, condition, emotional change, social limitation score total each dimension Minnesota living questionnaire scale obviously (p<0.05), group following treatment. The above scores decreased relative can enhance tolerance such cases, inhibit reverse remodeling, be beneficial improvement life.
منابع مشابه
Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
T he European Society of Cardiology (ESC) recently published new guidelines for the diagnosis and treatment of acute and chronic heart failure (HF). 1 The new nomenclature includes separating patients with HF into 3 distinct groups depending on the left ventricular ejection fraction (LVEF): preserved LVEF (≥50%), mid-range LVEF (40–49%), and reduced LVEF (≤40%). Although there have been several...
متن کاملUnderstanding Heart Failure With Mid-Range Ejection Fraction.
SEE PAGE 464 H eart failure (HF) with borderline or mid-range ejection fraction (HFmEF; 40% #EF <50%), the previously neglected “middle child of HF” (1), is increasingly receiving attention along with its famous older sibling, HF with reduced EF (HFrEF; EF <40%), and the favored baby of the HF family, HF with preserved EF (HFpEF; EF $50%). Prior knowledge on HFmEF was limited to a handful of st...
متن کاملHospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
Heart failure is highly prevalent with more than 50% of cases being patients with a preserved ejection fraction (HFPEF), a figure that is projected to increase due to the changing risk factor landscape, in particular the ageing population. Overall mortality is similar to patients with heart failure with reduced ejection fraction (HFREF), as are the rates of hospitalisation. Patients with HFPEF ...
متن کاملHeart Failure With Preserved Ejection Fraction
The Journal of the American Osteopathic Association July 2015 | Vol 115 | No. 7 432 From Henry Ford Wyandotte Downriver Cardiology in Brownstown, Michigan (Dr Rogers); West Suburban Medical Center in Oak Park, Illinois (Dr Gundala); Oakwood Southshore Medical Center in Trenton, Michigan (Dr Ramos); and Elmhurst Memorial Hospital in Illinois (Dr Serajian). Drs Gundala and Ramos are in their thir...
متن کاملHeart Failure With Preserved Ejection Fraction
Symptomatic heart failure, despite preserved left ventricular (LV) ejection fraction, is a well-recognized phenomenon. This manifestation of diastolic dysfunction is associated with increased morbidity and mortality and can be attributed to a variety of pathogeneses, including diabetes mellitus, hypertension, infiltrative processes, and obesity. Unlike in systolic heart failure, where LV ejecti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Pharmaceutical Sciences
سال: 2022
ISSN: ['0250-474X', '1998-3743']
DOI: https://doi.org/10.36468/pharmaceutical-sciences.spl.560